Hypotension

Disease4 papers1 finding

  • Human trial2
  • Humans1

Associations

1

Multicomponent blood pressure management strategy

upin humans1RR 1.58High certainty

1 study
  1. Multicomponent blood pressure management strategy raises the risk of hypotension in humans (RR 1.58 (95% CI 1.39-1.79)).

    Human trialhypertension7-year overall period

    Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial · Circulation · 28 Aug 2026

Multicomponent blood pressure management strategy →

Trial sponsors

Latest

Nov 2025: 2Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 3Aug 2026: 6Sep 2026: 5Oct 2026: 219
LancetHuman trial

Retatrutide reduces bodyweight in obesity and type 2 diabetes

Bodyweight fell by up to 18.8% with weekly retatrutide compared with 5.1% on placebo at week 80 in adults with obesity and type 2 diabetes.Bodyweight fell by up to 18.8% with weekly retatrutide compared with 5.1% on placebo at week 80 in adults with obesity and type 2 diabetes.